Literature DB >> 22871818

A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.

Swati Kulkarni1, Vasantha Kasiviswanathan, Kanjaksha Ghosh.   

Abstract

BACKGROUND: The D antigen is the most immunogenic antigen in the Rh system. D variants must be considered if there is a significant discrepancy in the strength of reaction obtained with different anti-D reagents, a discrepancy between current and historical test results and if anti-D is detected in an individual serologically typed as RhD positive. A panel of monoclonal anti-D reagents can be used to identify partial D and weak D variants. The aim of this study was to develop a strategy for RhD typing in discrepant cases.
MATERIALS AND METHODS: Sixty RhD discrepant samples referred to our Institute for confirmation of RhD status were tested with a panel of 12 monoclonal anti-D reagents (ALBAclone advanced partial RhD typing kit) and Rh phenotype was determined using C, c, D, E, and e antisera.
RESULTS: Ninety-three percent of the RhD discrepant cases were classified into weak and partial D using this kit. Among the D variants characterised, 37% belonged to DFR, 23% to DOL, 12% to weak D, and the remaining 21% to DAR, DV, DMH, DCS and DVI categories. Ninety-seven percent of the D variants were "C" antigen positive. Out of the panel of 12 monoclonal anti-D used, cell line LHM-70/45 gave negative reactions with all RhD discrepant cases and cell lines LHM-76/59, LHM-76/55 and ESD-1 gave positive reactions with all 60 RhD discrepant cases studied. DISCUSSION: The Advanced partial D kit was very useful in characterising and identifying D variants in the Indian population. A preliminary strategy for the detection and identification of D variants in discrepant cases could be to test for the presence of "C" antigen with anti-C, and for "D" antigen with anti-D of cell line LHM 70/45. A more comprehensive, but simple way to identify D variants in routine RhD typing is to use two anti-D reagents i.e LHM 70/45 and one out of LHM-76/59, LHM-76/55 and ESD-1. D variants can be further characterised by using the partial D typing kit and molecular genotyping in specialised laboratories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871818      PMCID: PMC3557475          DOI: 10.2450/2012.0006-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  22 in total

1.  Weak D alleles express distinct phenotypes.

Authors:  F F Wagner; A Frohmajer; B Ladewig; N I Eicher; C B Lonicer; T H Müller; M H Siegel; W A Flegel
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

2.  Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.

Authors:  M Williams
Journal:  Br J Biomed Sci       Date:  2000       Impact factor: 3.829

Review 3.  Molecular biology of partial D and weak D: implications for blood bank practice.

Authors:  Willy A Flegel; Franz F Wagner
Journal:  Clin Lab       Date:  2002       Impact factor: 1.138

4.  DNB: a partial D with anti-D frequent in Central Europe.

Authors:  Franz F Wagner; Nicole I Eicher; Jan R Jørgensen; Cornelie B Lonicer; Willy A Flegel
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

5.  RHD epitope density profiles of RHD variant red cells analyzed by flow cytometry.

Authors:  W A Flegel; F F Wagner
Journal:  Transfus Clin Biol       Date:  1996       Impact factor: 1.406

6.  Weak D and partial D in Slovenian population through serology and genotyping.

Authors:  R R Rupreht; K Pretnar Hartman; V Galvani; P Rozman; V Curin Serbec
Journal:  Pflugers Arch       Date:  2000       Impact factor: 3.657

7.  Ethnic populations of India as seen from an evolutionary perspective.

Authors:  P P Majumder
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

8.  Weak D type 42 cases found in individuals of European descent.

Authors:  Maryse St-Louis; Martine Richard; Marie Côté; Carole Ethier; Anne Long
Journal:  Immunohematology       Date:  2011

9.  Prevention of Rh alloimmunization.

Authors:  Karen Fung Kee Fung; Erica Eason; Joan Crane; Anthony Armson; Sandra De La Ronde; Dan Farine; Lisa Keenan-Lindsay; Line Leduc; Gregory J Reid; John Van Aerde; R Douglas Wilson; Gregory Davies; Valérie A Désilets; Anne Summers; Philip Wyatt; David C Young
Journal:  J Obstet Gynaecol Can       Date:  2003-09

Review 10.  Monoclonal anti-D specificity and Rh D structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors.

Authors:  J Jones; M L Scott; D Voak
Journal:  Transfus Med       Date:  1995-09       Impact factor: 2.019

View more
  4 in total

1.  The challenge and paradox in serology RhD typing for blood donors and patients.

Authors:  Catherine A Hyland
Journal:  Blood Transfus       Date:  2012-07-12       Impact factor: 3.443

2.  Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.

Authors:  Jelena Lukacevic Krstic; Slavica Dajak; Jasna Bingulac-Popovic; Vesna Dogic; Jela Mratinovic-Mikulandra
Journal:  J Clin Lab Anal       Date:  2017-06-26       Impact factor: 2.352

3.  Transfusion medicine in India: Expanding horizons.

Authors:  Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2014

4.  Impact of a confirmatory RhD test on the correct serologic typing of blood donors.

Authors:  Luciana Cayres Schmidt; Lilian Castilho; Otavio Vinicius Neves Vieira; Emília Sippert; Ane Caroline Gaspardi; Marina Lobato Martins; Maria Clara Fernandes da Silva Malta
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.